Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AJAX NYSE:ARA NYSE:MMM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAJAXAjax I$8.89$7.55▼$13.85$540.24MN/A1.21 million shs61,955 shsARAAmerican Renal Associates$11.52$11.50$5.57▼$11.98$397.94M1.11106,940 shs9,831 shsMMM3M$144.38-3.2%$149.78$119.31▼$164.15$76.92B1.054.05 million shs4.07 million shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAJAXAjax I0.00%0.00%0.00%0.00%0.00%ARAAmerican Renal Associates0.00%0.00%0.00%0.00%0.00%MMM3M-3.26%-4.56%-6.14%+1.63%+13.19%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAJAXAjax IN/AN/AN/AN/AN/AN/AN/AN/AARAAmerican Renal AssociatesN/AN/AN/AN/AN/AN/AN/AN/AMMM3M4.4614 of 5 stars2.25.02.52.83.62.51.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAJAXAjax I 0.00N/AN/AN/AARAAmerican Renal Associates 0.00N/AN/AN/AMMM3M 2.45Hold$158.109.50% UpsideCurrent Analyst Ratings BreakdownLatest ARA, AJAX, CRES, and MMM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/29/2025MMM3MWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold (C+) ➝ Hold (C+)7/18/2025MMM3MWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight7/18/2025MMM3MJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$167.007/18/2025MMM3MBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$170.007/17/2025MMM3MBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$170.00 ➝ $172.007/12/2025MMM3MWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold (C+) ➝ Hold (C+)7/9/2025MMM3MBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$164.00 ➝ $170.007/1/2025MMM3MWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$150.00 ➝ $170.006/27/2025MMM3MWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold (C+) ➝ Hold (C+)6/11/2025MMM3MWeiss RatingsSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold (C+) ➝ Hold (C+)(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAJAXAjax IN/AN/AN/AN/AN/AN/AARAAmerican Renal Associates$822.52M0.48$1.69 per share6.80$2.59 per share4.45MMM3M$24.60B3.13$9.68 per share14.91$8.17 per share17.67Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAJAXAjax IN/AN/A0.00N/AN/AN/AN/AN/AN/AARAAmerican Renal Associates-$13.79M$0.26N/AN/AN/A-2.04%-3.56%-0.24%N/AMMM3M$4.17B$7.1920.0817.332.8916.01%96.48%10.62%N/ALatest ARA, AJAX, CRES, and MMM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails7/18/2025Q2 2025MMM3M$2.01$2.16+$0.15$1.34$6.09 billion$6.16 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAJAXAjax IN/AN/AN/AN/AN/AARAAmerican Renal AssociatesN/AN/AN/AN/AN/AMMM3M$2.922.02%N/A40.61%1 YearsLatest ARA, AJAX, CRES, and MMM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date5/13/2025MMM3Mquarterly$0.731.94%5/23/20256/12/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAJAXAjax IN/AN/AN/AARAAmerican Renal Associates7.541.051.02MMM3M2.871.721.20Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAJAXAjax I52.68%ARAAmerican Renal Associates78.42%MMM3M65.25%Insider OwnershipCompanyInsider OwnershipAJAXAjax IN/AARAAmerican Renal Associates9.50%MMM3M0.34%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAJAXAjax I389.44 millionN/ANot OptionableARAAmerican Renal Associates4,97734.54 millionN/AOptionableMMM3M61,500532.63 million530.82 millionOptionableARA, AJAX, CRES, and MMM HeadlinesRecent News About These CompaniesMackenzie Financial Corp Buys 8,898 Shares of 3M Company (NYSE:MMM)2 hours ago | marketbeat.comAssetmark Inc. Purchases 4,316 Shares of 3M Company (NYSE:MMM)2 hours ago | marketbeat.comINVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former or Current 3M Company (NYSE:MMM)August 1 at 10:06 AM | bakersfield.comBGSA Capital Partners LLP Acquires 5,634 Shares of 3M Company (NYSE:MMM)August 1 at 7:44 AM | marketbeat.comFiera Capital Corp Invests $5.29 Million in 3M Company (NYSE:MMM)August 1 at 7:20 AM | marketbeat.comAegis Wealth Management LLC Buys 4,411 Shares of 3M Company (NYSE:MMM)July 31 at 7:52 AM | marketbeat.comHarvest Fund Management Co. Ltd Boosts Holdings in 3M Company (NYSE:MMM)July 31 at 7:52 AM | marketbeat.comLPL Financial LLC Boosts Stock Position in 3M Company (NYSE:MMM)July 31 at 7:52 AM | marketbeat.comRoyce & Associates LP Sells 6,000 Shares of 3M Company (NYSE:MMM)July 31 at 7:52 AM | marketbeat.com3M’s (MMM) Commitment to Innovation Drives Dividend GrowthJuly 31 at 4:43 AM | msn.comWeiss Ratings Reiterates Hold (C+) Rating for 3M (NYSE:MMM)July 31 at 2:29 AM | americanbankingnews.com3M (NYSE:MMM) Receives Hold (C+) Rating from Weiss RatingsJuly 30 at 2:41 AM | marketbeat.comWhy Investors Need to Take Advantage of These 2 Multi-Sector Conglomerates Stocks NowJuly 29, 2025 | zacks.comBanque Cantonale Vaudoise Invests $7.25 Million in 3M Company (NYSE:MMM)July 29, 2025 | marketbeat.com3M Company (NYSE:MMM) Holdings Reduced by Premier Fund Managers LtdJuly 29, 2025 | marketbeat.com3M Company (NYSE:MMM) Stock Position Lessened by Foundations Investment Advisors LLCJuly 29, 2025 | marketbeat.comNorden Group LLC Boosts Stake in 3M Company (NYSE:MMM)July 29, 2025 | marketbeat.comTD Asset Management Inc Sells 2,889 Shares of 3M Company (NYSE:MMM)July 29, 2025 | marketbeat.comPacer Advisors Inc. Reduces Stake in 3M Company (NYSE:MMM)July 29, 2025 | marketbeat.comScotch Brand celebrates 100 Years of adhesive solutions and industrial innovationJuly 28, 2025 | prnewswire.com3M: A Reliable American GiantJuly 28, 2025 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military Spend3 Short Squeeze Candidates With Big Catalysts on the HorizonBy Dan Schmidt | July 25, 2025View 3 Short Squeeze Candidates With Big Catalysts on the HorizonRocket Lab: A Parabolic Run Meets a Healthy PullbackBy Ryan Hasson | July 23, 2025View Rocket Lab: A Parabolic Run Meets a Healthy PullbackAs Bitcoin Hits New Highs, These 3 Stocks Could ExplodeBy Gabriel Osorio-Mazilli | July 21, 2025View As Bitcoin Hits New Highs, These 3 Stocks Could ExplodeCyclical Rebound or False Start for These 3 Stocks?By Gabriel Osorio-Mazilli | July 17, 2025View Cyclical Rebound or False Start for These 3 Stocks?ARA, AJAX, CRES, and MMM Company DescriptionsAjax I NYSE:AJAXAjax I does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Ajax I was founded in 2020 and is based in New York, New York.American Renal Associates NYSE:ARAAmerican Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts.3M NYSE:MMM$144.38 -4.84 (-3.24%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$144.50 +0.12 (+0.08%) As of 08/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.3M Company provides diversified technology services in the United States and internationally. The company's Safety and Industrial segment offers industrial abrasives and finishing for metalworking applications; autobody repair solutions; closure systems for personal hygiene products, masking, and packaging materials; electrical products and materials for construction and maintenance, power distribution, and electrical original equipment manufacturers; structural adhesives and tapes; respiratory, hearing, eye, and fall protection solutions; and natural and color-coated mineral granules for shingles. Its Transportation and Electronics segment provides ceramic solutions; attachment/bonding products, films, sound, and temperature management for transportation vehicles; premium large format graphic films for advertising and fleet signage; light management films and electronics assembly solutions; packaging and interconnection solutions; semiconductor production materials; data centers solutions; and reflective signage for highway, and vehicle safety. The company's Consumer segment provides consumer bandages, braces, supports, and consumer respirators; home cleaning products; retail abrasives, paint accessories, car care DIY products, picture hanging, and consumer air quality solutions; and stationery products. It offers its products through e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers. 3M Company was founded in 1902 and is headquartered in Saint Paul, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Why Bloom Energy Stock Could Break to New Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
